Oxford Immunotec (OXFD) Tops Q1 EPS by 5c, Beats on Revenues

Oxford Immunotec (NASDAQ: OXFD) reported Q1 EPS of ($0.40), $0.05 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $21.4 million versus the consensus estimate of $20.96 million.

GUIDANCE:

Oxford Immunotec sees FY2018 revenue of $112-115 million.

For earnings history and earnings-related data on Oxford Immunotec (OXFD) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Rithm Capital earns S&P upgrade to ’B+’ following steady revenue diversification
• General Mills (GIS) Tops Q1 EPS by 3c